Moderna Just Gave Investors Another Reason to Buy the Stock
- Stock Market Stocks to buy Stocks to sell
admin
- 0
- 1 minute read
Moderna (NASDAQ: MRNA) is best known for its work in the coronavirus vaccine market. That’s why the company’s stock skyrocketed in the earlier days of the pandemic. It’s also why its shares have lagged over the past three years — its COVID-19 vaccine sales dropped off a cliff.
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-896777854-ad6104867244456183e949439c5b652e.jpg "<div>TQQQ vs. QQQ: What's the Difference?</div>")
:max_bytes(150000):strip_icc():format(jpeg)/100krent-01c80567bd7845b99e2b8261c7c03a0c.jpg "How Far Does a 0k Salary Really Go When It Comes to Rent?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1365436662-4169cf80a9c04d75bb7766dd652ec603.jpg "Retirement Security Rule: What It Is and What It Means for Investors")